Asset
BNT-152 MRNA
BioNTech SE American Depositary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04710043 | phase1 | completed | 2021-06-08 | 2025-09-10 | BioNTech SE | Dose Escalation Trial of BNT152+153 in Patients With Cancer |
FDA applications (0)
This company has no applications containing this asset.